Background Adhesive capsulitis is a common disorder characterized by severe shoulder pain and progressive limitation of active and passive glenohumeral movements (1,2).
Objectives The aim of this study was to eveluate the effects of suprascapular nerve block (SSNB) combined with physical therapy (PT) on patients' pain and functional status.
Methods Forty one patients with adhesive capsulitis were randomly assigned to SSNB group (n:19) and PT alone group (n:22). All patients received 15 sessions PT consisting of ultrasound therapy, superficial heat application, analgesic current and range of motion (ROM) and stretching exercises. The patients in the study group received SSNB with before PT. SSNB was applied with triamsinolone and prilokain at the suprascapular notch. Outcome measures were evaluated three times, before treatment, at the end of the treatment, and after one month of treatment. Pain was assessed by Brief Pain Inventory (BPI), ROM and functional status were assessed by total Constant score.
Results Both treatment groups improved significantly in all follow-up parameters (p<0.05) except for BPI-9c of PT group (p>0.05). Comparisons of the differences between groups indicated that, 1-2, 1-3. evaluations of BPI-5, 1-2. evaluation of BPI-6, 1-2. evaluation of BPI-9a, 1-2, 1-3. evaluations of BPI-9g were statistically significant in SSNB group (table-1). No complications or drop outs occurred during the trial.
Conclusions Although better results were achieved in SSNB group, both treatments found to be effective in reducing pain severity and fuctional disability. These findings suggest that suprascapular nerve block is a safe and effective alternative in patients with adhesive capsulitis.
Dahan THM, Fortine L,Pelletier M. Double blind randomized clinical trial examining the efficacy of suprascapular nerve block in frozen shoulder. The J Rheumatol. 2000;27:1464-1469
Taşkaynatan MA, Yılmaz B, Özgül A.Yazıcıoğlu K, Kalyon TA.Suprascapular nerve block versus steroid injection for non-spesific shoulder pain. Tohoku J. Exp.Med. 2005;205:19-25
Disclosure of Interest None declared